1. Treatment Outcomes with Biosimilars: Be Aware of the Nocebo Effect

   • Mourad F. Rezk
   • Burkhard Pieper

   Review Open access 14 October 2017 Pages: 209 - 218

   

2. Improving the Management of Psoriatic Arthritis and Axial Spondyloarthritis: Roundtable Discussions with Healthcare Professionals and Patients

   • Marco Garrido-Cumbrera
   • Ottfrid Hillmann
   • Laura C. Coates

   Review Open access 09 June 2017 Pages: 219 - 231

3. A Review of the Use of Secukinumab for Psoriatic Arthritis

   • Nupur U. Patel
   • Nora C. Vera
   • Steven R. Feldman

   Review Open access 28 August 2017 Pages: 233 - 246

   

4. Treatment with Biologicals in Rheumatoid Arthritis: An Overview

   • Philipp Rein
   • Ruediger B. Mueller

   Review/CME Article Open access 22 August 2017 Pages: 247 - 261

5. Chronic Autoimmune Epithelitis in Sjögren’s Syndrome and Primary Biliary Cholangitis: A Comprehensive Review

   • Carlo Selmi
   • M. Eric Gershwin

   Review Open access 08 August 2017 Pages: 263 - 279

6. Identification and Treatment Optimization of Comorbid Depression in Rheumatoid Arthritis

   • Mellissa H. Withers
   • Louella T. Gonzalez
   • George A. Karpouzas

   PRACTICAL APPROACH/CME ARTICLE Open access 16 August 2017 Pages: 281 - 291

7. Practical Management of Cardiovascular Comorbidities in Rheumatoid Arthritis

   • Roberta Gualtierotti
   • Nicola Ughi
   • Francesca Ingegnoli

   Practical approach/CME article Open access 27 July 2017 Pages: 293 - 308

   

8. Practical Management of Respiratory Comorbidities in Patients with Rheumatoid Arthritis

   • James Bluett
   • Meghna Jani
   • Deborah P. M. Symmons

   Practical Approach Open access 14 August 2017 Pages: 309 - 332

   

9. Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis

   • Katelynn M. Wilton
   • Eric L. Matteson

   Practical Approach Open access 15 May 2017 Pages: 333 - 347

10. Comparative Effectiveness of Adalimumab versus Secukinumab for the Treatment of Psoriatic Arthritis: A Matching-Adjusted Indirect Comparison

    • Vibeke Strand
    • Keith A. Betts
    • Avani Joshi

    Original Research Open access 31 July 2017 Pages: 349 - 362

    

11. Switching From Immediate-Release to Delayed-Release Prednisone in Moderate to Severe Rheumatoid Arthritis: A Practice-Based Clinical Study

    • Ara H. Dikranian
    • Rubaiya Mallay
    • Robert J. Holt

    Original Research Open access 17 August 2017 Pages: 363 - 374

    

12. Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry

    • Dimitrios A. Pappas
    • Joel M. Kremer
    • Vishvas Garg

    Original Research Open access 24 August 2017 Pages: 375 - 389

    

13. Single-Arm Study of Etanercept in Adult Patients with Moderate to Severe Rheumatoid Arthritis Who Failed Adalimumab Treatment

    • Louis Bessette
    • Majed Khraishi
    • David Collier

    Original Research Open access 12 September 2017 Pages: 391 - 404

    

14. Impact of Tocilizumab Monotherapy on Clinical and Patient-Reported Quality-of-Life Outcomes in Patients with Rheumatoid Arthritis

    • Leslie R. Harrold
    • Ani John
    • Jeffrey D. Greenberg

    Original Research Open access 21 September 2017 Pages: 405 - 417

    

15. Treatment with Allopurinol is Associated with Lower Risk of Acute Kidney Injury in Patients with Gout: A Retrospective Analysis of a Nested Cohort

    • Fernando Perez-Ruiz

    Original Research Open access 27 September 2017 Pages: 419 - 425

16. Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective

    • Rebekah H. Borse
    • Chloe Brown
    • Sumesh Kachroo

    Original Research Open access 27 September 2017 Pages: 427 - 443

    

17. Chronic Disease and Self-Injection: Ethnographic Investigations into the Patient Experience During Treatment

    • Michael Schiff
    • Shane Saunderson
    • Paul Hartley

    Original Research Open access 27 September 2017 Pages: 445 - 463

    

18. A Retrospective Medical Record Review of Utilization Patterns and Medical Resource Use Associated with Repository Corticotropin Injection among Patients with Rheumatologic Diseases in the United States

    • Winnie W. Nelson
    • Michael J. Philbin
    • George J. Wan

    Original Research Open access 25 October 2017 Pages: 465 - 474

    

19. Secukinumab in Active Rheumatoid Arthritis after Anti-TNFα Therapy: A Randomized, Double-Blind Placebo-Controlled Phase 3 Study

    • Hasan Tahir
    • Atul Deodhar
    • Hanno B. Richards

    Original Research Open access 14 November 2017 Pages: 475 - 488

    

20. Discontinuation of Biologic Therapy in Rheumatoid Arthritis: Analysis from the Corrona RA Registry

    • Vibeke Strand
    • Paul Miller
    • Joel Kremer

    Brief Report Open access 22 August 2017 Pages: 489 - 502

    

21. Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series

    • Morton Scheinberg
    • Regina Adalva de Lucena Couto Océa
    • Sineida Berbert Ferreira

    Case Series Open access 28 July 2017 Pages: 503 - 508

    

22. A Case of Recalcitrant Psoriatic Arthritis to TNF Inhibitors Improved After Administration of Secukinumab, an IL-17A Inhibitor

    • Eleftherios Pelechas
    • Tereza Memi
    • Alexandros A. Drosos

    Case Report Open access 11 October 2017 Pages: 509 - 513

    

23. The Effect Size of Fibromyalgia on PG-VAS in Rheumatoid Arthritis Patients. Adjustment Proposal in DAS28-ESR: Letter to the Editor regarding Challa, D.N.V., Crowson, C.S. & Davis, J.M. Rheumatol Ther (2017) 4: 201. doi:10.1007/s40744-017-0063-5

    • David Vega-Morales
    • Luis Ivan Lozano-Plata
    • Jorge Antonio Esquivel-Valerio

    Letter Open access 06 July 2017 Pages: 515 - 517